Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

The Journal of Urology
R ShabsighH Padma-Nathan

Abstract

We compare the efficacy of testosterone gel (T-gel) versus placebo as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. A randomized, placebo controlled, double-blind, parallel group, multicenter study was performed. A total of 75 hypogonadal men (18 to 80 years old, morning serum total testosterone 400 ng/dl or less) with confirmed lack of response to sildenafil monotherapy were randomized (1:1) to receive a daily dose of 1% T-gel or 5 gm placebo gel as adjunctive therapy to 100 mg sildenafil during a 12-week period. Subjects were evaluated for sexual function, primarily based on the International Index of Erectile Function (IIEF), quality of life and serum testosterone levels at baseline and weeks 4, 8 and 12. Testosterone treated subjects had greater improvement in erectile function compared to those who received placebo, reaching statistical significance at week 4 (4.4 vs 2.1, p = 0.029, 95.1% CI 0.3, 4.7). Similar trends were observed for improvements in orgasmic function, overall satisfaction, total IIEF score and percentage of IIEF responders. T-gel significantly (p < or = 0.004) increased total and free testosterone levels throughout the study, although...Continue Reading

References

Feb 24, 1993·JAMA : the Journal of the American Medical Association
Jul 7, 1993·JAMA : the Journal of the American Medical Association
Oct 7, 1997·International Journal of Impotence Research·A R Fugl-MeyerK S Fugl-Meyer
Jul 12, 2002·The Urologic Clinics of North America·Mark A Moyad
Jul 5, 2003·Current Medical Research and Opinion·Andrea SaloniaFrancesco Montorsi

❮ Previous
Next ❯

Citations

Jul 22, 1999·Urology·W D Steers
Jun 25, 2010·International Journal of Impotence Research·T MostafaK Kotb
Jul 25, 2009·International Journal of Clinical Practice·R SadovskyS Sorsaburu
Oct 12, 2013·The Journal of Sexual Medicine·Emmanuele A JanniniStanley E Althof
Mar 24, 2011·The Journal of Sexual Medicine·Giovanni CoronaMario Maggi
May 25, 2010·The Journal of Sexual Medicine·Eric Chung
Jun 11, 2014·The Journal of Sexual Medicine·Yongxian LiYong Cheng
Feb 2, 2011·Medical Hypotheses·Onder Canguven, Selami Albayrak
Jul 6, 2013·BJU International·Mikkel FodeJens Sønksen
Feb 13, 2010·Sociology of Health & Illness·Barbara L Marshall
Oct 15, 2013·Lancet·Shehzad Basaria
Oct 9, 2012·Lancet·Rany Shamloul, Hussein Ghanem
Sep 23, 2016·PloS One·Samantha HuoAdriane Fugh-Berman
Feb 17, 2015·Korean journal of urology·Jae Heon Kim, Seung Wook Lee
Aug 18, 2017·Current Opinion in Urology·Paul J RizkMohit Khera
Oct 18, 2014·Journal of Pediatric Endocrinology & Metabolism : JPEM·Leena NahataLaurie E Cohen
May 22, 2019·Frontiers in Endocrinology·Antonio AversaSandro La Vignera
Jul 16, 2009·Current Opinion in Obstetrics & Gynecology
Apr 25, 2009·Current Opinion in Endocrinology, Diabetes, and Obesity

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.